Abstract:Objective:This study aims to explore the predictive value of preoperative C-reactive protein (CRP) and other inflammatory biomarkers: platelet-to-lymphocyte ratio (PLR) and neutrophil-to-lymphocyte ratio (NLR) for postoperative complications (infection, diarrhea, etc.) in colorectal tumor patients. Methods:A cohort of 109 colorectal tumor patients who underwent surgical resection for colorectal cancer at the hospital from January 2021 to December 2022 were selected as the research subjects. Patients' postoperative complications were tracked, and they were split into the complication group and the non-complication group. All patients underwent preoperative biochemical tests. Serum levels of CRP, PLR, and NLR were compared between the two groups. The relationship between these markers and postoperative complications in colorectal tumor patients was analyzed. A Logistic regression model was established to analyze their impact on postoperative complications, and a Receiver Operating Characteristic (ROC) curve was drawn to assess predictive value. Results:Among the 109 colorectal tumor patients, 31 cases (28.44%) experienced postoperative complications. The complication group had larger tumor diameters and a higher proportion of open surgeries compared to the non-complication group (P < .05). Serum levels of CRP, PLR, and NLR were higher in the complication group compared to the non-complication group (P < .05). Correlation analysis showed that serum CRP, PLR, and NLR values were positively correlated with postoperative complications in colorectal tumor patients (r > 0, P < .05). The Logistic regression model revealed that high serum CRP levels (95%CI: 1.253-2.503), PLR (95%CI: 1.005-1.041), and NLR values (95%CI: 2.702-20.533) were risk factors for postoperative complications in colorectal tumor patients (OR>1, P < .05). The ROC curve demonstrated that serum CRP levels, PLR, and NLR values had certain predictive values for postoperative complications in colorectal tumor patients (AUC=0.811, 0.789, 0.870), the optimal predictive values were obtained when the cut-off values were set at 5.400 mg/L, 142.790, and 2.485, respectively and combined detection showed even higher predictive values (AUC=0.913). At 1 week post-surgery, the patient's CRP levels, PLR value, and NLR value were significantly lower than pre-surgery (P < .05). Conclusion:Preoperative serum CRP, PLR, and NLR values are closely related to postoperative complications in colorectal tumor patients, and they can be used to predict the risk of postoperative complications in colorectal tumor patients. Clinically, early prediction of postoperative complications in patients can be achieved by measuring the aforementioned indicators, allowing for the implementation of appropriate preventive measures such as detoxification and infection control to improve patient outcomes.

Postoperative renormalization of C-reactive protein with adjuvant lienal polypeptide and its association with tumour recurrence in T1 clear cell renal cell carcinoma.

Preoperative C-reactive Protein/albumin Ratio to Predict Mortality and Recurrence of Patients with Hepatocellular Carcinoma after Curative Resection.

Prognostic Significance of Preoperative C-reactive Protein: Albumin Ratio in Patients with Clear Cell Renal Cell Carcinoma.

Preoperative C-reactive protein/albumin ratio predicts outcome of surgical papillary renal cell carcinoma.

Preoperative Neutrophil-to-Lymphocyte Ratio and Neutrophilia Are Independent Predictors of Recurrence in Patients with Localized Papillary Renal Cell Carcinoma

C-reactive protein predicts pathologic complete response to neoadjuvantchemotherapy in breast cancer

Preoperative Inflammation-Associated Blood Cell Markers in Patients with Non-Metastatic Clear Cell Renal Cell Carcinoma: A Retrospective Study

Postoperative C-reactive protein/albumin ratio is a biomarker of risk of recurrence and need for adjuvant chemotherapy for stage III colorectal cancer

Predictive Value of Preoperative Neutrophil-to-lymphocyte Ratio in Non-Metastatic Papillary Renal Cell Carcinoma Patients after Receiving Curative Surgery

Positive Intratumoral Chemokine (C-C Motif) Receptor 8 Expression Predicts High Recurrence Risk Of Post-Operation Clear-Cell Renal Cell Carcinoma Patients

[Clinical Significance of C-reactive Protein in Patients with Stage I Non-Small Cell Lung Cancer].

The C-reactive Protein/albumin Ratio, a Validated Prognostic Score, Predicts Outcome of Surgical Renal Cell Carcinoma Patients

Preoperative C-reactive Protein and Other Inflammatory Biomarkers As Predictors of Postoperative Complications in Colorectal Tumor Patients.

Expression of CRP protein in lung adenocarcinoma and its prognostic significance

The Prognostic Value of C-reactive Protein in Renal Cell Carcinoma: A Systematic Review and Meta-Analysis

High Expression of Chemokine CCL2 is Associated with Recurrence after Surgery in Clear-Cell Renal Cell Carcinoma

The value of C-reactive protein in the evaluation of the prognosis of renal cancer

Preoperative serum C-reactive protein levels and postoperative survival in patients with esophageal squamous cell carcinoma: a propensity score matching analysis

Elevated serum C-reactive protein level predicts a poor prognosis for recurrent gastric cancer

[Preoperative C-reactive Protein/albumin Ratio Predicts the Prognosis of Patients with Resectable Pancreatic Cancer].

Granulocyte Macrophage Colony-Stimulating Factor Predicts Postoperative Recurrence of Clear-Cell Renal Cell Carcinoma.